Erythrocyte protoporphyrin fluorescence as a biomarker for monitoring antiangiogenic cancer therapy

Journal of Fluorescence

Volumn 20, Issue 6, 2010, Pages 1225-1231

  De Góes Rocha, Flávia Gomes ^a,b   Chaves, Karen Cristina Barbosa ^a,b   Gomes, Cinthia Zanini ^a   Campanharo, Camila Barricheli ^b   Courrol, Lilia Coronato ^a,b   Schor, Nestor ^b   Bellini, Maria Helena ^a,b  

^a INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Animal model; Endostatin; Fluorescence; Metastasis; Porphyrin; RCC

Indexed keywords

ANIMAL MODEL; ANTI-ANGIOGENIC ACTIVITY; ANTI-ANGIOGENIC THERAPY; ANTIANGIOGENIC; AUTO FLUORESCENCES; CANCER THERAPY; CONTROL GROUPS; CONTROL SAMPLES; EMISSION SPECTRUMS; ENDOSTATINS; FLUORESCENCE INTENSITIES; FLUORESCENCE PEAK; LUNG NODULE; METASTASIS; MICROVASCULAR; MOUSE MODELS; ORTHOTOPIC; PROTOPORPHYRINS; RCC; RENAL CELL CARCINOMA; SELECTIVE DETECTION; SPECTRAL REGION; TUMOR MASS; WET WEIGHT;

ANIMALS; BIOLOGICAL ORGANS; EMISSION SPECTROSCOPY; ENZYME INHIBITION; FLUORESCENCE SPECTROSCOPY; ONCOLOGY; PATHOLOGY; PORPHYRINS; SPECTROSCOPIC ANALYSIS;

FLUORESCENCE;

ANGIOGENESIS INHIBITOR; PROTOPORPHYRIN; TUMOR MARKER;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL LINE; CHEMISTRY; DISEASE MODEL; ERYTHROCYTE; FLUORESCENCE; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METASTASIS; MOUSE; PATHOLOGY; SPECTROFLUOROMETRY; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; CARCINOMA, RENAL CELL; CELL LINE; DISEASE MODELS, ANIMAL; ERYTHROCYTES; FLUORESCENCE; KIDNEY NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; PROTOPORPHYRINS; SPECTROMETRY, FLUORESCENCE; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA;

EID: 78650793108     PISSN: 10530509     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10895-010-0672-7     Document Type: Article

References (29)

1. T Tonini F Rossi PP Claudio 2003 Molecular basis of angiogenesis and cancer Oncogene 22 6549 6556 1:CAS:528:DC%2BD3sXnsl2rs7o%3D 10.1038/sj.onc. 1206816 14528279
2. K Gupta JD Miller JZ Li MW Russell C Charbonneau 2008 Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review Cancer Treat Rev 34 193 205 10.1016/j.ctrv.2007.12.001 18313224
3. WH Chow SS Devesa JL Warren JF Fraumeni Jr 1999 Rising incidence of renal cell cancer in the United States JAMA 281 1628 1631 1:STN:280: DyaK1M3kvFagtA%3D%3D 10.1001/jama.281.17.1628 10235157 (Pubitemid 29211773)
4. JM Hollingsworth DC Miller S Daignault BK Hollenbeck 2007 Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis Cancer 109 1763 1768 10.1002/cncr.22600 17351954 (Pubitemid 46668538)
5. J Assouad B Petcova P Berna A Dujon C Foucault M Riquet 2007 Renal cell carcinoma metastases surgery: pathologic findings and prognostic factors Ann Thorac Surg 84 4 1114 1120 10.1016/j.athoracsur.2007.04.118 17888956 (Pubitemid 47417869)
6. L Weiss JP Harlos J Torhost B Gunthard F Hartveit E Svendsen WL Huang E Grundmann M Eder M Zwicknagl HR Cochrane D Stock C Wright CHW Horne 1988 Metastatic patterns of renal carcinoma: an analysis of 687 necropsies J Cancer Res Clin Oncol 114 605 612 1:STN:280:DyaL1M%2FnvFOnsA%3D%3D 10.1007/BF00398185 3204107 (Pubitemid 19011678)
7. H Saitoh 1981 Distant metastasis of renal adenocarcinoma Cancer 48 1487 1491 1:STN:280:DyaL38%2FgtF2itw%3D%3D 10.1002/1097-0142(19810915)48:6<1487:: AID-CNCR2820480635>3.0.CO;2-9 7272969 (Pubitemid 11042605)
8. EL Coutinho LNS Andrade R Chammas L Morganti N Schor MH Bellini 2007 Anti-tumor effect of endostatin mediated by retroviral gene transfer in mice bearing renal cell carcinoma FASEB J 21 3153 3161 1:CAS:528:DC%2BD2sXhtFKntbvF 10.1096/fj.07-8412com 17513560
9. R Kerbel J Folkman 2002 Clinical translation of angiogenesis inhibitors Nat Rev Cancer 2 727 739 1:CAS:528:DC%2BD38XnsVGrtb0%3D 10.1038/nrc905 12360276 (Pubitemid 37328908)
10. I Martin-Padura F Bertolini 2009 Circulating endothelial cells as biomarkers for angiogenesis in tumor progression Front Biosci (Schol Ed) 1 304 318
11. J Folkman 2004 Endogenous angiogenesis inhibitors APMIS 112 496 507 1:CAS:528:DC%2BD2MXls1Ghtg%3D%3D 10.1111/j.1600-0463.2004.apm11207-0809.x 15563312 (Pubitemid 39626056)
12. T Boehm J Folkman T Browder MS O'Relly 1997 Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature 390 404 407 1:CAS:528:DyaK2sXns12rsL8%3D 10.1038/37126 9389480 (Pubitemid 28027321)
13. MS O'Reilly T Boehm Y Shing N Fukai G Vasios WS Lane E Flynn JR Birkhead BR Olsen J Folkman 1997 Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 277 285 10.1016/S0092-8674(00)81848-6 9008168 (Pubitemid 28015876)
14. M Kirsch G Schackert PM Black 2000 Angiogenesis, metastasis, and endogenous inhibition J Neuro-oncology 50 173 180 1:STN:280: DC%2BD3Mzmsl2luw%3D%3D 10.1023/A:1006453428013 (Pubitemid 32166299)
15. EA Te Velde JM Vogten MFGB Gebbink JM Van Gorp EE Voest IHMB Rinkes 2002 Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model Br J Surg 89 1302 1309 1:STN:280:DC%2BD38vos1Gjsw%3D%3D 10.1046/j.1365-2168.2002.02183.x 12296902 (Pubitemid 36002551)
16. SP Schantz HE Savage P Sacks RR Alfano 1997 Native cellular fluorescence and its application to cancer prevention Environ Health Perspect 105 Suppl 4 941 1:CAS:528:DyaK2sXls1elsL4%3D 10.2307/3433308 9255585
17. N Ramanujam 2000 Fluorescence spectroscopy of neoplastic and non-neoplastic tissues Neoplasia 2 1-2 89 117 1:STN:280:DC%2BD3cvhvFKqtA%3D%3D 10.1038/sj.neo.7900077 10933071
18. KS Chang P Ina N Marin M Follen R Richards-Kortum 2005 Fluorescence spectroscopy as a diagnostic tool for detecting cervical pre-cancer Gynecol Oncol 99 S61 S63 10.1016/j.ygyno.2005.07.045 16419187 (Pubitemid 41774315)
19. M Vogeser K Jacob R Zachoval 2000 Erythrocyte protoporphyrins in hepatitis C viral infection Clin Biochem 33 5 387 391 1:CAS:528: DC%2BD3cXnvVertbo%3D 10.1016/S0009-9120(00)00149-1 11018691
20. LC Courrol FRO Silva EL Coutinho MF Piccoli RD Mansano ND Vieira N Schor MH Bellini 2007 Study of blood porphyrin spectral profile for diagnosis of tumor progression J Fluoresc 17 3 289 292 1:CAS:528:DC%2BD2sXkvVagsLY%3D 10.1007/s10895-007-0171-7 17393286 (Pubitemid 46686165)
21. MH Bellini EL Coutinho LC Courrol FRO Silva ND Vieira N Schor 2008 Correlation between autofluorescence intensity and tumor area in mice bearing renal cell carcinoma J Fluoresc 18 6 1163 1168 1:CAS:528:DC%2BD1cXhsVWjt73E 10.1007/s10895-008-0368-4 18488145
22. Y Kusunoki F Imamura H Uda M Mano T Horai 2000 Early detection of lung cancer with laser-induced fluorescence endoscopy and spectrofluorometry Chest 118 1776 1782 1:STN:280:DC%2BD3M%2FoslKkuw%3D%3D 10.1378/chest.118.6.1776 11115472 (Pubitemid 32001809)
23. TM Tsai RL Hong JC Tsai 2004 Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells Lasers Surg Med 34 64 72
24. H Heyerdahl I Wang DL Liu R Berg S Andersson-Engels Q Peng J Moan S Svanberg K Svanberg 1997 Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX, accumulation in tumors and normal tissues Cancer Lett 112 225 231 1:CAS:528:DyaK2sXpt12mtQ%3D%3D 10.1016/S0304-3835(96)04576-4 9066732 (Pubitemid 27104299)
25. Z Malik G Kostenich L Roitman B Ehrenberg A Orenstein 1995 Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumors of mice J Photochem Photobiol B 28 213 218 1:CAS:528:DyaK2MXmvF2kurc%3D 10.1016/1011-1344(95)07117-K 7623186
26. EWJ Van Der Breggen AI Rem MM Cristian CJ Yang KH Calhoun HJCM Sterenborg M Motamedi 1996 Spectroscopic detection of oral and skin tissue transformation in a model for squamous cell carcinoma: autofluorescence versus systemic aminolevulinic acid-induced fluorescence IEEE J Sel Top Quantum Electron 2 997 1007 10.1109/2944.577329
27. KT Moesta B Ebert T Handke D Nolte C Nowak WE Haensch RK Pandey TJ Dougherty H Rinneberg PM Schlag 2001 Protoporphyrin IX occurs naturally in colorectal cancers and their metastases Cancer Res 61 991 999 1:CAS:528:DC%2BD3MXhsFSru7o%3D 11221895
28. T Tsuji Y Sasaki M Tanaka N Hanabata R Hada A Munakata 2002 Microvessel morphology and vascular endothelial growth factor expression in human colonic carcinoma with or without metastasis Lab Invest 82 555 562 1:CAS:528: DC%2BD38Xks1Wksr0%3D 10.1038/labinvest.3780450 12003996 (Pubitemid 34522368)
29. L Hlatky P Hahnfeldt J Folkman 2002 Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us J Natl Cancer Inst 94 883 893 12072542